Determination of binding affinities of retinoids to retinoic acid-binding protein and serum albumin.
Binding affinities of retinoic acid and its synthetic analogues to intracellular retinoic acid-binding protein, which is a possible candidate for mediating their biological function, and to serum albumin, the plasma transport protein, were evaluated. A quantitative method involving elimination of interfering serum albumin by immunoprecipitation was developed to measure the binding efficiency of these retinoids, some of which are active in modifying epithelial differentiation and preventing tumorigenesis. Two cyclopentenyl analogues of retinoic acid and 13-cis-retinoic acid showed, like retinoic acid, a binding efficiency of 100% for the cellular binding protein. With the phenyl, dichlorophenyl and trimethylmethoxyphenyl analogues of retinoic acid, the binding efficiency increased as the substituents on the aromatic ring increased; thus the trimethylmethoxyphenyl analogue binds almost as efficiently as retinoic acid itself. However, the trimethylmethoxyphenyl analogue with a sulphur atom on the side chain has a much decreased binding affinity. The correlation noticed between the binding efficiency of these retinoids and their biological activity in differentiation and/or in the control of tumorigenesis particularly enhances the confidence in the present method of determining the relative binding efficiencies. None of the vitamins, hormones and cofactors tested, showed appreciable affinity for the retinoic acid-binding site. Studies on binding of retinoic acid and its analogues to serum albumin indicate that no correlation exists between binding affinity for albumin and their biological potency.
D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism*; D002499:Centrifugation, Density Gradient; D002642:Chick Embryo; D006728:Hormones / Q000494:pharmacology; D066298:In Vitro Techniques; D009712:Nucleotides, Cyclic / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D012709:Serum Albumin / Q000378:metabolism*; D012867:Skin / Q000378:metabolism; D014212:Tretinoin / Q000378:metabolism*; D014801:Vitamin A / Q000031:analogs & derivatives*; D014815:Vitamins / Q000494:pharmacology
D002352:Carrier Proteins; D006728:Hormones; D009712:Nucleotides, Cyclic; D011453:Prostaglandins; D012709:Serum Albumin; D014815:Vitamins; D014801:Vitamin A; D014212:Tretinoin